Jon Sponheim
- MD; PhD
- +47 23 07 24 69
Publications 2024
Diarrhoea of unknown cause: medical treatment in a stepwise manner<b>Management of Idiopathic Diarrhoea Based on Experience of Step-Up Medical Treatment</b>
Scand J Gastroenterol, 59 (5), 543-546
DOI 10.1080/00365521.2024.2313061, PubMed 38343268
Publications 2020
Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease
BMC Cancer, 20 (1), 466
DOI 10.1186/s12885-020-06963-6, PubMed 32448245
Publications 2017
Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation
Neuroradiology, 59 (2), 105-126
DOI 10.1007/s00234-017-1804-4, PubMed 28255902
Publications 2015
The biliary epithelium presents antigens to and activates natural killer T cells
Hepatology, 62 (4), 1249-59
DOI 10.1002/hep.27840, PubMed 25855031
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences
J Invest Dermatol, 135 (7), 1771-1780
DOI 10.1038/jid.2015.85, PubMed 25739051
Publications 2014
European panel on the appropriateness of gastrointestinal endoscopy II guidelines help in selecting and prioritizing patients referred to colonoscopy--a quality control study
Scand J Gastroenterol, 49 (4), 492-500
DOI 10.3109/00365521.2014.886715, PubMed 24597781
Publications 2012
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
The alarmin IL-33 is a notch target in quiescent endothelial cells
Am J Pathol, 181 (3), 1099-111
DOI 10.1016/j.ajpath.2012.06.003, PubMed 22809957
Publications 2011
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
Scand J Gastroenterol, 46 (9), 1081-91
DOI 10.3109/00365521.2011.584897, PubMed 21619483
Publications 2010
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts
Am J Pathol, 177 (6), 2804-15
DOI 10.2353/ajpath.2010.100378, PubMed 21037074
Publications 2009
Interleukin-33 - cytokine of dual function or novel alarmin?
Trends Immunol, 30 (5), 227-33
DOI 10.1016/j.it.2009.03.003, PubMed 19359217
Publications 2008
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation
Am J Pathol, 173 (4), 1229-42
DOI 10.2353/ajpath.2008.080014, PubMed 18787100